| 000 | 01412 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513191906.0 | ||
| 264 | 0 | _c19991007 | |
| 008 | 199910s 0 0 eng d | ||
| 022 | _a0006-291X | ||
| 024 | 7 |
_a10.1006/bbrc.1999.1275 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRahbar, S | |
| 245 | 0 | 0 |
_aNovel inhibitors of advanced glycation endproducts. _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _cSep 1999 |
||
| 300 |
_a651-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntibodies |
| 650 | 0 | 4 |
_aButyrates _xchemical synthesis |
| 650 | 0 | 4 |
_aDipeptides _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xdrug effects |
| 650 | 0 | 4 |
_aGlycation End Products, Advanced _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIndicators and Reagents |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aRibonucleases _xchemistry |
| 650 | 0 | 4 | _aRibose |
| 650 | 0 | 4 |
_aSerum Albumin _xdrug effects |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 | _aGlycated Serum Albumin |
| 700 | 1 | _aKumar Yernini, K | |
| 700 | 1 | _aScott, S | |
| 700 | 1 | _aGonzales, N | |
| 700 | 1 | _aLalezari, I | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 262 _gno. 3 _gp. 651-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/bbrc.1999.1275 _zAvailable from publisher's website |
| 999 |
_c10428883 _d10428883 |
||